therapeutic strategies

OXFORD: e-therapeutics plc has entered a collaboration agreement with Galapagos NV to identify new therapeutic approaches to modulate a specific mechanism involved in idiopathic pulmonary fibrosis (IPF) and potentially in other fibrotic indications. e-therapeutics will continue to be free to…